| Enliven Therapeutics, Inc. |
10%+ Owner |
Common Stock |
3,200,634 |
$47,689,447 |
$14.90 |
14 Feb 2024 |
By 5AMVentures VI, L.P. |
| Enliven Therapeutics, Inc. |
10%+ Owner |
Common Stock |
635,341 |
$9,466,581 |
$14.90 |
14 Feb 2024 |
By 5AM Opportunities I, L.P. |
| Camp4 Therapeutics Corp |
10%+ Owner |
Common Stock |
2,941,176 |
$4,499,999 |
$1.53 |
11 Sep 2025 |
By 5AM Ventures VII, L.P. |
| Camp4 Therapeutics Corp |
10%+ Owner |
Common Stock |
2,625,145 |
$3,753,957 |
$1.43 |
11 Sep 2025 |
By 5AM Ventures VI, L.P. |
| Camp4 Therapeutics Corp |
10%+ Owner |
Common Stock |
302,770 |
$432,961 |
$1.43 |
11 Sep 2025 |
By 5AM Opportunities II, L.P. |
| Artiva Biotherapeutics, Inc. |
10%+ Owner |
Common Stock |
1,182,054 |
|
|
22 Jul 2024 |
By 5AM Opportunities II, L.P. |
| Artiva Biotherapeutics, Inc. |
10%+ Owner |
Common Stock |
1,171,250 |
|
|
22 Jul 2024 |
By 5AM Ventures VI, L.P. |
| Artiva Biotherapeutics, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
22 Jul 2024 |
By 5AM Ventures VI, L.P. |
| Artiva Biotherapeutics, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
22 Jul 2024 |
By 5AM Ventures VI, L.P. |
| Camp4 Therapeutics Corp |
10%+ Owner |
Series A Prime Preferred Stock |
0 |
|
|
15 Oct 2024 |
By 5AM Ventures VI, L.P. |
| Camp4 Therapeutics Corp |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
15 Oct 2024 |
By 5AM Opportunities II, L.P. |
| Camp4 Therapeutics Corp |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
15 Oct 2024 |
By 5AM Ventures VI, L.P. |
| CinCor Pharma, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$28.75 |
24 Feb 2023 |
By 5AM Opportunities II, L.P. |
| CinCor Pharma, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$28.75 |
24 Feb 2023 |
By 5AM Opportunities I, L.P. |
| CinCor Pharma, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$28.75 |
24 Feb 2023 |
By 5AM Ventures VI, L.P. |